QUEBEC CITY, Aug. 4 /CNW Telbec/ - DiagnoCure Inc. (TSX: CUR), a life
sciences company commercializing high-value cancer diagnostic tests and
delivering laboratory services, announced today that four prominent colorectal
cancer key opinion leaders have agreed to serve on the Strategic Advisory
Board of its wholly owned subsidiary, DiagnoCure Oncology Laboratories.
